Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Tempus AI, Inc. Class A Common Stock (TEM) Insider Trading Activity
Healthcare • Health Information Services • 0 employees
Tempus AI, Inc operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company also offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a collaboration with united therapeutics to study use of AI to detect patients at risk for pulmonary hypertension. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc in January 2023. Tempus AI, Inc was incorporated in 2015 and is headquartered in Chicago, Illinois.
Total Value
-$117,703,551.48
Total Shares
604,854
Average Trade Value
-$2,675,080.72
Most Active Insider
Red Sky Ventures Llc
Total Activity: $79,762,500
Largest Single Transaction
$49,200,000
by Red Sky Ventures Llc on Dec 11, 2024
30-Day Activity
38 Transactions
Volume: 3,085,146 shares
Value: $135,468,551
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
---|---|---|---|---|---|---|
CEO and Chairman
|
Dec 18, 2024 | 3,338 | $127,712 | 9,561,752 (-0.0%) | Sale | |
CEO and Chairman
|
Dec 18, 2024 | 16,176 | $620,026 | 26,594,143 (-0.1%) | Sale | |
CEO and Chairman
|
Dec 18, 2024 | 116,813 | $4,361,797 | 26,610,319 (-0.4%) | Sale | |
CEO and Chairman
|
Dec 18, 2024 | 42,193 | $1,576,330 | 9,565,090 (-0.4%) | Sale | |
CEO and Chairman
|
Dec 18, 2024 | 4,666 | $183,747 | 26,589,477 (-0.0%) | Sale | |
CEO and Chairman
|
Dec 18, 2024 | 4,469 | $175,721 | 9,557,283 (-0.0%) | Sale | |
Chief Accounting Officer
|
Dec 16, 2024 | 339 | $13,638 | 71,007 (-0.5%) | Sale | |
EVP Chief Admin Legal Off
|
Dec 16, 2024 | 2,396 | $96,391 | 220,596 (-1.1%) | Sale | |
Chief Operating Officer
|
Dec 16, 2024 | 3,500 | $140,805 | 1,003,707 (-0.3%) | Sale | |
EVP and General Counsel
|
Dec 16, 2024 | 1,130 | $45,460 | 244,955 (-0.5%) | Sale | |
Chief Financial Officer
|
Dec 16, 2024 | 1,468 | $59,058 | 229,812 (-0.6%) | Sale | |
EVP Chief Admin Legal Off
|
Dec 12, 2024 | 10,264 | $452,129 | 222,992 (-4.6%) | Sale | |
EVP and General Counsel
|
Dec 11, 2024 | 3,900 | $159,432 | 293,689 (-1.3%) | Sale | |
Chief Operating Officer
|
Dec 11, 2024 | 60,279 | $2,588,983 | 1,023,926 (-5.9%) | Sale | |
EVP and General Counsel
|
Dec 11, 2024 | 20,420 | $852,535 | 273,269 (-7.5%) | Sale | |
EVP and General Counsel
|
Dec 11, 2024 | 22,040 | $946,838 | 251,229 (-8.8%) | Sale | |
Chief Operating Officer
|
Dec 11, 2024 | 10,976 | $448,479 | 1,116,231 (-1.0%) | Sale | |
EVP and General Counsel
|
Dec 11, 2024 | 5,144 | $224,381 | 246,085 (-2.1%) | Sale | |
Chief Operating Officer
|
Dec 11, 2024 | 32,026 | $1,335,484 | 1,084,205 (-3.0%) | Sale | |
10% Owner
|
Dec 11, 2024 | 130,016 | $5,524,367 | 16,430,233 (-0.8%) | Sale | |
Chief Financial Officer
|
Dec 11, 2024 | 26,578 | $1,109,100 | 274,787 (-9.7%) | Sale | |
Chief Financial Officer
|
Dec 11, 2024 | 12,940 | $528,340 | 301,365 (-4.3%) | Sale | |
Chief Financial Officer
|
Dec 11, 2024 | 35,899 | $1,542,580 | 238,888 (-15.0%) | Sale | |
Chief Financial Officer
|
Dec 11, 2024 | 7,608 | $331,937 | 231,280 (-3.3%) | Sale | |
10% Owner
|
Dec 11, 2024 | 265,784 | $11,473,443 | 16,164,449 (-1.6%) | Sale | |
10% Owner
|
Dec 11, 2024 | 1,200,000 | $49,200,000 | 15,360,249 (-7.8%) | Sale | |
Chief Operating Officer
|
Dec 11, 2024 | 16,719 | $728,781 | 1,007,207 (-1.7%) | Sale | |
10% Owner
|
Dec 11, 2024 | 750,000 | $30,562,500 | 14,610,249 (-5.1%) | Sale | |
Dec 11, 2024 | 233,149 | $9,698,998 | 3,260,948 (-7.1%) | Sale | ||
Dec 11, 2024 | 620 | $25,922 | 27,894 (-2.2%) | Sale | ||
Dec 11, 2024 | 210,000 | $179,382 | 210,000 (+100.0%) | Exercise/Conversion | ||
Dec 11, 2024 | 166,851 | $6,795,841 | 3,494,097 (-4.8%) | Sale | ||
Dec 11, 2024 | 4,153 | $179,368 | 205,847 (-2.0%) | Payment of Exercise Price | ||
Dec 11, 2024 | 1,183 | $49,461 | 37,331 (-3.2%) | Sale | ||
EVP Chief Admin Legal Off
|
Dec 11, 2024 | 6,939 | $283,528 | 308,426 (-2.2%) | Sale | |
EVP Chief Admin Legal Off
|
Dec 11, 2024 | 8,910 | $388,743 | 233,256 (-3.8%) | Sale | |
EVP Chief Admin Legal Off
|
Dec 11, 2024 | 24,894 | $1,038,578 | 283,532 (-8.8%) | Sale | |
EVP Chief Admin Legal Off
|
Dec 11, 2024 | 41,366 | $1,777,497 | 242,166 (-17.1%) | Sale | |
Chief Financial Officer
|
Nov 1, 2024 | 30,000 | $0 | 314,305 (+9.5%) | Grant | |
EVP and General Counsel
|
Nov 1, 2024 | 30,000 | $0 | 297,589 (+10.1%) | Grant | |
EVP Chief Admin Legal Off
|
Nov 1, 2024 | 20,000 | $10,000 | 315,365 (+6.3%) | Grant | |
Chief Accounting Officer
|
Nov 1, 2024 | 10,000 | $0 | 71,346 (+14.0%) | Grant | |
10% Owner
|
Aug 16, 2024 | 3,500,000 | $17,745,000 | 12,718,800 (+27.5%) | Purchase | |
Chief Operating Officer
|
Aug 1, 2024 | 100,000 | $10,000 | 1,277,207 (+7.8%) | Grant |